Latest Regulatory News

Elanor Investors Group announces a $125 million recapitalisation through an expanded alliance with Rockworth Capital Partners, including the acquisition of Singapore’s Firmus Capital and a strategic shift towards Pan-Asian real estate markets.

Stanmore Resources has reported a robust recovery in its June quarter operations with increased coal production, zero serious safety incidents, and positive cash flow, despite challenging weather conditions. The company maintains its full-year production guidance, signaling resilience amid market uncertainties.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.

Zenith Minerals reports a landmark quarter with a 41% increase in gold resources at Dulcie Far North, a strategic land acquisition, and a successful A$3.5 million entitlement offer to accelerate exploration.

Jcurve Solutions has raised $1 million through a strategic share placement at a significant premium, bringing on a new investor with deep Oracle NetSuite expertise and appointing a nominee director to its board.

Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.

Carnegie Clean Energy has signed a pivotal Memorandum of Understanding with BiMEP to develop a 6MW wave energy array in Spain’s Basque Country, marking a significant step in commercialising its CETO technology.

Carawine Resources advances exploration planning at Paterson and other projects while facing a pivotal court decision on shareholder compulsory acquisition and securing a $1.7 million loan to sustain operations.

Viridis Mining and Minerals has been selected by Brazil's BNDES and FINEP to receive significant funding under a US$903 million strategic minerals initiative, accelerating its Colossus rare earths project and downstream operations.

Imricor Medical Systems reported significant regulatory and commercial progress in Q2 CY25, including CE mark approvals and expanded clinical trials, while maintaining a strong cash position.

Fitzroy River Corporation reported steady royalty income for the March 2025 quarter despite operational suspensions at Buru and ongoing geopolitical risks impacting commodity markets. Key project updates include Bowdens Silver’s development application progress and Federation Mining’s Snowy River feasibility study.

Sprintex has landed a landmark three-year private-label supply agreement worth A$9.3 million with Guangdong Baode Technology, marking its entry into China’s vast aquaculture market.